Abdelrahim, M.; Esmail, A.; Saharia, A.; Abudayyeh, A.; Abdel-Wahab, N.; Diab, A.; Murakami, N.; Kaseb, A.O.; Chang, J.C.; Gaber, A.O.;
et al. Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View. Cancers 2022, 14, 1760.
https://doi.org/10.3390/cancers14071760
AMA Style
Abdelrahim M, Esmail A, Saharia A, Abudayyeh A, Abdel-Wahab N, Diab A, Murakami N, Kaseb AO, Chang JC, Gaber AO,
et al. Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View. Cancers. 2022; 14(7):1760.
https://doi.org/10.3390/cancers14071760
Chicago/Turabian Style
Abdelrahim, Maen, Abdullah Esmail, Ashish Saharia, Ala Abudayyeh, Noha Abdel-Wahab, Adi Diab, Naoka Murakami, Ahmed O. Kaseb, Jenny C. Chang, Ahmed Osama Gaber,
and et al. 2022. "Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View" Cancers 14, no. 7: 1760.
https://doi.org/10.3390/cancers14071760
APA Style
Abdelrahim, M., Esmail, A., Saharia, A., Abudayyeh, A., Abdel-Wahab, N., Diab, A., Murakami, N., Kaseb, A. O., Chang, J. C., Gaber, A. O., & Ghobrial, R. M.
(2022). Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View. Cancers, 14(7), 1760.
https://doi.org/10.3390/cancers14071760
